Robot-assisted urologic surgery: safety and feasibility in the pediatric population.

PURPOSE: To assess the safety and feasibility of performing robot-assisted pediatric urologic surgery with the da Vinci Surgical System (Intuitive Surgical, Inc, Sunnyvale, Calif) based on our experience with a variety of procedures. PATIENTS AND METHODS: A retrospective review was performed of 53 robot-assisted pediatric procedures performed in our practice between September 2003 and March 2006. The procedures included 11 renal extirpative surgeries, 10 orchiopexies, 26 dismembered pyeloplasties, 2 uretero-ureterostomies, and 3 bladder surgeries. The mean patient age was 7.7 years, and the mean patient weight was 32 kg. All procedures were performed transperitoneally. RESULTS: All procedures were successfully completed with no conversions to open surgery. There was one procedure in which the robotic system malfunctioned, resulting in an unrecoverable loss of three-dimensional visualization and temporary loss of color. The only postoperative complication involved delayed return of bowel function that led to a diagnostic laparotomy with negative findings. A decrease in mean postoperative stay was noted in patients who underwent robot-assisted procedures compared with previous patients who had undergone open surgery. CONCLUSION: Robot-assisted surgery appears to be safe and feasible for a variety of pediatric urologic procedures. Prospective randomized studies are required to further evaluate the outcomes compared with open surgical procedures. Our initial experience has been encouraging and will serve as a foundation for future and more complex minimally invasive pediatric urologic operations.

Transition from open to robotic-assisted radical prostatectomy: 7 years experience at Hackensack University Medical Center.

Background and objective Open radical prostatectomy (ORP) is the standard approach for the surgical management of localized prostate cancer. The steep learning curve for laparoscopic prostatectomy poses a challenge for surgeons with minimal laparoscopic experience. As robotic-assisted surgery becomes more prevalent in the urologic community, there appears to be an increasing interest in robotic-assisted radical prostatectomy (RARP) among urologists throughout the United States. We report on the impact of robotics on practice patterns in the treatment of localized prostate cancer at a single institution. Methods A retrospective review was conducted of radical prostatectomies performed between January 2000 and December 2006 at Hackensack University Medical Center (Hackensack, N.J.). Over this time period, our medical center acquired four da Vinci™ Surgical Systems. The trends for open and robotic-assisted prostatectomies were analyzed. Results Over a 7-year period (2000-2006), a total of 1252 radical prostatectomies were performed by 17 urologists: 469 (37%) ORPs and 783 (63%) RARPs. The total number of prostatectomies increased annually during this time period. The robotic-assisted procedure was predominantly performed by three (18%) urologists from 2001-2003, seven (41%) in 2004, nine (53%) in 2005, and 11 (65%) in 2006. As more urologists became trained in robotic-assisted surgery, the trend gradually shifted towards robotic-assisted prostatectomy. In 2001, only 9.6% of all radical prostatectomies at our institution were performed with robotic assistance; in 2006, this had risen to 92.8%. Conclusion The acquisition of the da Vinci™ Surgical System has allowed robotic-assisted surgery to be an available alternative to open surgery at a single institution. The implementation of robotic technology has led to the gradual adoption of robotic-assisted radical prostatectomy by many of the urologists that surgically treat prostate cancer. As a result, the percentage of open prostatectomies has steadily decreased over time, while trends in robotic-assisted prostatectomies have increased. The impact of robotics also appears to have had an influential effect on the total number of prostatectomies performed annually.

Adrenal insufficiency: diagnosis and management.

Adrenal insufficiency is a disorder characterized by hypoactive adrenal glands resulting in insufficient production of the hormones cortisol and aldosterone by the adrenal cortex. This disorder may develop as a primary failure of the adrenal cortex or be secondary to an abnormality of the hypothalamic-pituitary axis. Patients with adrenal insufficiency often are asymptomatic or they may present with fatigue, muscle weakness, weight loss, low blood pressure, and sometimes darkening of the skin. The presentation of adrenal insufficiency varies dramatically and poses a major diagnostic dilemma. This review focuses on the diagnosis and treatment of primary and secondary adrenal insufficiency.